2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

»çȸ¹®Á¦¸¦ ÇØ°áÇϴ û³â 478¸íÀÇ ¡®º£À̽ºÄ·ÇÁ¡¯°¡ µÇ´Ù

10³â°£ 478¸íÀÇ ¼ö·á»ý ¹èÃ⡦ ÀÓÆÑÆ® »ýŰè ÀÎÀç µî¿ë¹® ¿ªÇÒ
ºñ¿µ¸® »ç´Ü¹ýÀÎ ·çÆ®ÀÓÆÑÆ®°¡ ‘ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ(Impact Basecamp)’ ÇÁ·Î±×·¥ 10ÁÖ³âÀ» ¸Â¾Æ ¼ö·á»ýÀÇ º¯È­¿Í ÇÁ·Î±×·¥ÀÇ ¼º°ú¸¦ ´ãÀº ÀÓÆÑÆ® ¸®Æ÷Æ®¸¦ ¹ß°£ÇÏ°í ±â³äÇà»ç¸¦ °³ÃÖÇß´Ù. ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ´Â û³âµéÀÌ »çȸ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿ª·®À» ±â¸£°í, À̸¦ Ä¿¸®¾î ¼ºÀå°ú ¿¬°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â ±³À° ÇÁ·Î±×·¥ÀÌ´Ù. ¾à 8ÁÖ~16ÁÖ°£ »çȸ¹®Á¦¸¦ Á¤ÀÇÇϰí Á÷Á¢ ¹®Á¦ ÇØ°á ¹æ¹ýÀ» µµÃâÇÏ´Â ÇÁ·ÎÁ§Æ® ±â¹Ý ÇнÀ(Project Based Learning, PBL) ¹æ½ÄÀ¸·Î ÁøÇàµÈ´Ù. 2015³â ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç±îÁö 478¸íÀÇ ¼ö·á»ýÀ» ¹èÃâ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¡®Á¦ÁÖ ¼Ò»ó°øÀÎ 3Ç÷¯½º Èñ¸Áµå¸² Ä«µå¡¯ Ãâ½Ã (2025-07-03)
SES Receives All Required Regulatory Approvals to Complete I... (2025-07-20)
¼­¿ïµ·È­¹®±¹¾Ç´ç ´ëÇ¥ ·¹ÆÛÅ丮 2025 ¡®»êÁ¶´ëÀü¡¯ °ø¿¬ (2025-02-25)
Ä«Æ÷½º ¡®Á¤ºñÀÎÀÇ ³¯ Çà»ç¡¯ °³ÃÖ (2025-03-22)
ÇÑÈ­¿¡¾î·Î½ºÆäÀ̽º, 3.6Á¶¿ø ÅõÀÚ ±Û·Î¹ú Åé-Ƽ¾î µµ¾à ¼±¾ð (2025-03-21)
±èÁöÇö, tvN ¡®¼­Ãʵ¿¡¯ Ã⿬ (2025-06-15)
´ººô¸®Æ¼, »ê¾÷´ÜÁö ½ÄÀ½·á ·Îº¿¹è´Þ »ó¿ëÈ­ (2025-07-02)
Á¦³×½Ã½º, PGA Åõ¾î ù °ø½Ä ÀÚµ¿Â÷ ÈÄ¿ø»ç µÈ´Ù (2025-07-02)
¾î¶»°Ô ÆÈÁö ¸·¸·ÇÒ ¶§ Àд īÇÇ Ã¥ (2024-06-02)
ºÎ»ê±¤¿ª½Ã ³ëÀÎÀÏÀÚ¸® Âü¿©ÀÚ ´ë»ó ±ÝÀ¶»ç±â ¿¹¹æ±³À° ÁøÇà (2025-03-27)
¡®¶Ù¾î¾ß »ê´Ù¡¯ À²Èñ, Æ®·¹ÀÏ ·¯´× Áß Å»¼ö¿¡ ¾²·¯Áö±â±îÁö? (2025-06-14)
100% ±¹»ê ÅäÁ¾ °ËÀºÄáÀ¸·Î ¸¸µç ¡®¼­¸®Å ÅäÀ塯 (2025-03-06)
Laserfiche Recognized as a 2025 Gartner¢ç Peer Insights¢â ¡°... (2025-07-19)
LG¡¯s Latest Sustainability Report Highlights Progress Towar... (2025-07-19)
LXÇÏ¿ì½Ã½º ¡®¿¢½ºÄÄÆ÷Æ®¡¯ ¹Ù´ÚÀç ¸®´º¾ó ½ÅÁ¦Ç° Ãâ½Ã (2024-05-30)
¼¼½ºÄÚ, ¼¼°èÀÚ¿¬±â±Ý°ú ÇÔ²² ÇØ¾ç »ý¹° ´Ù¾ç¼º º¸Àü ½Çõ (2025-03-29)
½ºÅ¸®±×·ì, KRX±Ý½ÃÀå Àû°Ý±ÝÁö±Ý¼öÀÔ¾÷ÀÚ·Î ¼±Á¤ (2025-03-19)
¹Ì·¡¿£ µðÁöÅÐÃÊÄÚ, ¼¼°è½ºÇÇµå°ø±â´ëȸ °ø½Ä ÈÄ¿ø (2025-06-10)
SiPearl: Final closing of ¢æ130m Series A with Cathay Ventur... (2025-07-18)
¼¾¼­ Çϳª·Î À§Ä¡ ÃßÁ¤ °¡´É '3Â÷¿ø ¸¶ÀÌÅ©' ¼¼°è ÃÖÃÊ °³¹ß (2025-06-09)
ÃÊÀúÀü·Â µðÁöÅÐ ±¤°íÆÇ ¡®»ï¼º Ä÷¯ ÀÌÆäÀÌÆÛ¡¯ Ãâ½Ã (2025-06-09)
ÇØ¿î´ë¿¬Åº»ý°¥ºñ, º£Æ®³² È£Âî¹Î 1È£Á¡ 3¿ù ¿ÀÇ (2024-02-17)
µ¿¿øÈ¨Çªµå, ºñºñµåŰģ Àú´ç Á¶¸®¾ç³ä 7Á¾ Ãâ½Ã (2025-06-28)
Áß¼Ò ESCO ¼ºÀå »ýŰè Á¶¼º À§ÇØ ¸ÅÃâä±Ç À¯µ¿È­ Áö¿ø (2025-03-22)
°í¼Òµæ °ÔÀÌ¸Ó Àý¹Ý ÀÌ»ó, ¸ð¹ÙÀÏ °ÔÀÓ ³» ±¤°í¿¡ ¡®±àÁ¤Àû¡¯ (2025-05-19)
       [ÀÌÀü][1]....[165][166][167][168][169][170][171][172][173]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..